Population pharmacokinetics and limited sampling strategy for first-line tuberculosis drugs and moxifloxacin

International journal of antimicrobial agents

Volumn 44, Issue 3, 2014, Pages 229-234

  Magis Escurra, C ^a   Later Nijland, H M J ^a   Alffenaar, J W C ^a   Broeders, J ^a   Burger, D M ^a   van Crevel, R ^a   Boeree, M J ^a   Donders, A R T ^a   van Altena, R ^a   van der Werf, T S ^a   Aarnoutse, R E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Limited sampling strategy; Population pharmacokinetics; TB drugs

Indexed keywords

MOXIFLOXACIN; QUINOLONE DERIVATIVE; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; FEMALE; HUMAN; MALE; MIDDLE AGED; NETHERLANDS; TUBERCULOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; AREA UNDER CURVE; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; TUBERCULOSIS; YOUNG ADULT;

EID: 85027952108     PISSN: None     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.04.019     Document Type: Article

References (0)